Literature DB >> 9784496

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes.

R C Davies1, C Calvio, E Bratt, S H Larsson, A I Lamond, N D Hastie.   

Abstract

WT1 is essential for normal kidney development, and genetic alterations are associated with Wilms' tumor, Denys Drash (DDS), and Frasier syndromes. Although generally considered a transcription factor this study has revealed that WT1 interacts with an essential splicing factor, U2AF65, and associates with the splicing machinery. WT1 is alternatively spliced and isoforms that include three amino acids, KTS, show stronger interaction with U2AF65 in vitro and better colocalization with splicing factors in vivo. Interestingly a mutation associated with DDS enhanced both -KTS WT1 binding to U2AF65 and splicing-factor colocalization. These data illustrate the functional importance of WT1 isoforms and suggest that WT1 plays a role in pre-mRNA splicing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784496      PMCID: PMC317218          DOI: 10.1101/gad.12.20.3217

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  40 in total

1.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.

Authors:  F J Rauscher; J F Morris; O E Tournay; D M Cook; T Curran
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

2.  Mechanism of action of an acidic transcriptional activator in vitro.

Authors:  Y S Lin; M R Green
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

4.  Purification and visualization of native spliceosomes.

Authors:  R Reed; J Griffith; T Maniatis
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

5.  Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.

Authors:  W J Habets; M H Hoet; B A De Jong; A Van der Kemp; W J Van Venrooij
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  The candidate Wilms' tumour gene is involved in genitourinary development.

Authors:  K Pritchard-Jones; S Fleming; D Davidson; W Bickmore; D Porteous; C Gosden; J Bard; A Buckler; J Pelletier; D Housman
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease.

Authors:  E A Lerner; M R Lerner; C A Janeway; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4.

Authors:  K D Harshman; W S Moye-Rowley; C S Parker
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

10.  Identification of protein antigens associated with the nuclear matrix and with clusters of interchromatin granules in both interphase and mitotic cells.

Authors:  B M Turner; L Franchi
Journal:  J Cell Sci       Date:  1987-03       Impact factor: 5.285

View more
  60 in total

1.  Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.

Authors:  J H Laity; H J Dyson; P E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 3.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

4.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  A mammalian germ cell-specific RNA-binding protein interacts with ubiquitously expressed proteins involved in splice site selection.

Authors:  D J Elliott; C F Bourgeois; A Klink; J Stévenin; H J Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing.

Authors:  Yupeng Chen; Lirong Zhang; Katherine A Jones
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

7.  Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.

Authors:  Jonathan Lefebvre; Michael Clarkson; Filippo Massa; Stephen T Bradford; Aurelie Charlet; Fabian Buske; Sandra Lacas-Gervais; Herbert Schulz; Charlotte Gimpel; Yutaka Hata; Franz Schaefer; Andreas Schedl
Journal:  Kidney Int       Date:  2015-05-20       Impact factor: 10.612

8.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

9.  SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.

Authors:  Lina A Shehadeh; Kristine Yu; Liyong Wang; Alexandra Guevara; Carlos Singer; Jeffery Vance; Spyridon Papapetropoulos
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

10.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.